GUARD — Guard Therapeutics International AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK27.23m
- -SEK42.53m
Annual income statement for Guard Therapeutics International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 40.3 | 81.9 | 115 | 115 | 99.9 |
| Operating Profit | -40.3 | -81.9 | -115 | -115 | -99.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -40.3 | -82 | -113 | -113 | -96.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -40.3 | -82 | -113 | -113 | -96.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -40.3 | -82 | -113 | -113 | -96.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -40.3 | -82 | -113 | -113 | -96.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -9.18 | -11.5 | -15.4 | -10.8 | -8.26 |
| Dividends per Share |